Since T-ALL cells express high levels of MYC, which is essential for their proliferation (Sanchez-Martin and Ferrando, 2017), we hypothesize that WNK1 may contribute to the growth of T-ALL by maintaining high levels of MYC, making WNK1 a potential therapeutic target in this thymocyte-derived leukemia. This evidence concerns the gene MYC and leukemia.